LAMC2 and familial pancreatic carcinoma: Recently, Kosanam et al. have conducted a comprehensive PDAC tissue proteomic study that demonstrated both the prognostic and diagnostic potentials of Lamc2, and its behaviour in prospective biomarker panels for the improved pancreatic cancer diagnosis [99].